Tag: UK Pharma

UK Cleared Roche’s Proposed Purchase of Spark Therapeutics

The UK Competition and Markets Authority announced the clearance of Roche's proposed purchase of Spark Therapeutics after concluding that the deal would not negatively affect competition for haemophil...

NICE and SMC Published Positive Recommendations on Mulpleo®

Shionogi & Co., Ltd. and its European subsidiary, Shionogi B.V., announced that the National Institute for Health and Care Excellence (NICE) and Scottish Medicines Consortium (SMC) have published ...

Torbett Named New Chief Executive of ABPI

uk
Dr. Richard Torbett has been announced as the new Chief Executive of the Association of the British Pharmaceutical Industry (ABPI), from the beginning of 2020. Torbett joined the ABPI in July 2015 ...

Pfizer’s Ibrance Approved for Use by NHS in England

Pfizer’s Ibrance has been approved for use by the NHS in England as a second-line treatment for advanced breast cancer after hormonal therapy, catching up with rival drugs in the class. The decision ...

BioCity UK Life Science Start-Up Report Revealed a ‘Baby Boom’ of New Life Science Ventures

life-science
BioCity, the pioneering life science incubator and business collective releases its biennial publication, the UK Life Science Start-Up Report, an in-depth analysis of emerging businesses within the li...

NHS Confederation and Other UK Health Leaders Urge Government to Tackle Pressures

The NHS Confederation and other health leaders across the UK have urged the incoming Government to “address the critical issues that will improve and transform services for patients.” The bodies wa...

UK Government Invests £3.5m to Help Develop New Antibitoic Treatments for Gonorrhoea

The UK government has announced that it is to invest £3.5 million to help develop new treatments for gonorrhoea and make them available to low- and middle-income countries. The investme...

UK Plans to Loosen Rules on Low-Risk Clinical Trials in Post-Brexit Shakeup

uk
The United Kingdom government has proposed relaxing the regulatory requirements on the lowest risk clinical trials after it leaves the European Union. Officials made the proposal in a suite of changes...

UK’s Competition Watchdog Uncovered Illegal Agreement, Resulting in Huge Price Hikes

The UK’s competition watchdog has provisionally found three drug firms signed an illegal agreement, resulting in huge price hikes for an essential medicine used by the NHS. The Competition and Mark...

Procarta Announced Award to Progress Pipeline of Antibiotic Precision Meds

Procarta Biosystems, a privately held UK-based biotech company, announced a CARB-X award of up to $9.2 million to progress its pipeline of antibiotic precision medicines. The award includes initial no...

Meds Could Be Delayed Up to 6 Months in Worst Brexit Scenario

Medicine and medical product supply chains could experience “severe extended delays” for up to six months in the “worst case” scenario after the UK leaves the EU, according to a government report. ...

UK Government Invests over £130 mln to Tackle Serious Diseases

The UK government has announced an investment of over £130 million for new tech to tackle cancer and debilitating illnesses. The news means that thousands of NHS patients could receive faster diagn...

ABPI and NHS to Launch New Guidance for Joint Working

The Association of the British Pharmaceutical Industry (ABPI) has launched a new guidance for joint working between the NHS and industry, which sets out a ten-step process to scope, set up and monitor...

No-Deal Brexit Could “Devastate” NHS, Health Leaders Warn

A no-deal Brexit could “devastate” the NHS by disrupting the supply of life-saving medicine by up to six months, health leaders have warned. The British Medical Association, Royal College of Nursin...

£267,000 Grant for Cell Therapy Stabilisation Technologies

Atelerix Consortium awarded £267,000 Innovate UK Grant for collaboration with the Cell and Gene Therapy Catapult and Rexgenero on cell therapy stabilisation technologies. Rexgenero, a regenerative me...

HRT Shortage in UK to Continue Next Year

Around half of HRT products have been reported as out of stock in UK pharmacies due to supply issues in China, leading to a shortage. A shortage of hormone replacement therapy (HRT) in the UK has l...